U.S. Markets closed

Opexa Therapeutics, Inc. (OPXA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.749-0.007 (-0.958%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close0.756
Bid0.600 x 1000
Ask1.350 x 200
Day's Range0.720 - 0.750
52 Week Range0.500 - 4.930
Avg. Volume449,817
Market Cap5.74M
PE Ratio (TTM)-0.80
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journalslast month

    ​Cambridge rare disease startup Acer to go public through merger

    Acer Therapeutics, a three-year-old Cambridge biotech developing drugs for ultra-rare diseases, said Monday that it will go public through a reverse merger with a small Texas company. Acer said it would merge with Opexa Therapeutics (OPXA), which laid off all but two of its 20 employees after its lead drug for multiple sclerosis flunked a mid-stage trial in October. In connection with the deal, Acer said it would receive a $15.7 million round of financing led by TVM Capital, a life sciences venture firm based in Germany.

  • Zackslast month

    Company News for July 05, 2017

    Companies in the News are: RATE,EQT,MSDI,OPXA

  • TheStreet.com2 months ago

    Opexa Shares Jump on Merger with Acer Therapeutics

    After consummation Opexa's name will be changed to Acer Therapeutics Inc.